Healthcare
Explore reports in Healthcare Services
Select Industry
- All Industry Reports
Car T-Cell Therapy Market (By Product (Abecma (idecabtagene vicleucel), Breyanzi (lisocabtagene maraleucel), Carvykti (ciltacabtagene autoleucel), Kymriah (tisagenlecleucel), Tecartus (brexucabtagene autoleucel), Yescarta (axicabtagene ciloleucel), Others Products), By Disease Indication (Leukemia, Lymphoma, Multiple Myeloma, Other Disease Indications), By End-Use (Hospitals and Cancer Treatment Centers), By Region and Companies)
Global Car T-Cell Therapy Market size is expected to be worth around USD 19.5 Billion by 2033 from USD 3.3 Billion in 2023, growing at a CAGR of 18.2% during the forecast period from 2023 to 2033.
Clinical Trial Support Services Market (By Service (Clinical Trial Site Management, Patient Recruitment Management, Patient recruitment & registry services, Patient retention, Others, Data Management, Administrative staff, IRB, Other Services), By Phase (Phase I, Phase II, Phase III, Phase IV, Other Phase), By Sponsor (Pharmaceutical & Biopharmaceutical, Medical Devices, Other Sponsor), By Indication (Autoimmune or Inflammation, Cardiovascular, Diabetes, Oncology, Other Indication), By Region and Companies)
Global Clinical Trial Support Services Market size is expected to be worth around USD 49.3 Billion by 2033 from USD 23.1 Billion in 2023, growing at a CAGR of 7.8% during the forecast period from 2023 to 2033.
Global Pulmonary Arterial Hypertension Market (By Drug Class (Endothelin Receptor Antagonists (ERAs), PDE-5 Inhibitors, Prostacyclin and Prostacyclin Analogs, SGC Stimulators), By Type (Branded, Generics), By Route of Administration (Oral, Intravenous/ subcutaneous, Inhalational), By Region and Companies)
Global Pulmonary Arterial Hypertension Market size is expected to be worth around USD 12.3 Billion by 2033 from USD 7.3 Billion in 2023, growing at a CAGR of 5.4% during the forecast period from 2023 to 2033.
Global Cancer Therapeutics Biotherapeutic Market (By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Hormone Therapy, Biotherapy, Others), By Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer, Glioblastoma, Malignant Meningioma, Mesothelioma, Melanoma, Others), By End User (Hospitals & Clinics, Cancer Care Centers, Research Institutes, Others), By Region and Companies)
Global Cancer Therapeutics Biotherapeutic Market size is expected to be worth around USD 457.3 Billion by 2033 from USD 195.1 Billion in 2023, growing at a CAGR of 8.8% during the forecast period from 2023 to 2033.
Global Hydrogel Wound Filler Market (By Product, Amorphous Hydrogel Dressings, Hydrogel Sheets, Impregnated Gauze, and Other Products; By Type, Diabetic Foot Ulcers, Surgical & Traumatic Wounds, Pressure Ulcers, Burns, Venous Leg Ulcers, And Other Types; By End-User, Hospitals, Specialty Clinics, and Other End-Users, By Region and Companies), 2024-2033
Hydrogel Wound Filler Market growth is projected to reach USD 0.5 Billion in 2023, at a 6.3% CAGR by driving industry size, share, segments research, top company analysis, trends and forecast report 2024 to 2033.
Global Biodefence Market (By Product, Anthrax, Botulism, Smallpox, Radiation/Nuclear, and Other Products; By End-User, Hospitals & Clinics, Ambulatory Care Centers, and Other End-Users; By Region and Companies), 2024-2033
Biodefence Market growth is projected to reach USD 16.3 Billion in 2023, at a 6.6% CAGR by driving industry size, share, segments research, top company analysis, trends and forecast report 2024 to 2033.
Global Drug Eluting Balloons Market (By Product, Peripheral Drug Eluting Balloon, Coronary Drug Eluting Balloon, and Other Products; By Technology, TransPax, Paccocath, FreePac, EnduraCoat, and Other Technologies; By End-User, Hospitals, Ambulatory Surgical Centers, and Other End-Users, By Region and Companies), 2024-2033
Drug Eluting Balloons Market growth is projected to reach USD 693.5 Million in 2023, at a 7.9% CAGR by driving industry size, share, segments research, top company analysis, trends and forecast report 2024 to 2033.
Global Enteral Feeding Formulas Market (By Product Type, Standard Formulas, Peptide Based, Disease-specific Formulas, Blenderized, and Immune Modulating; By Age Group, Adult and Child; By Application, Neurological Disorders, Cancer, Gastrointestinal Disorders, Malnutrition, and Other Applications; By End-User, Hospital, Long term Care Facilities, and Other End-Users; By Region and Companies), 2024-2033
Enteral Feeding Formulas Market growth is projected to reach USD 6.9 Billion in 2023, at a 8.3% CAGR by driving industry size, share, segments research, top company analysis, trends and forecast report 2024 to 2033.
Global Heparin Market (By Product, Low Molecular Weight Heparin and Unfractionated Heparin; By Source, Porcine and Bovine; By Application, Venous Thromboembolism, Coronary Artery Disease, Atrial Fibrillation/Flutter, and Other Applications; By Distribution Channel, Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy; By Region and Companies), 2024-2033
Heparin Market growth is projected to reach USD 7.4 Billion in 2023, at a 3.2% CAGR by driving industry size, share, segments research, top company analysis, trends and forecast report 2024 to 2033.
Global Spatial Genomics Market (By Product, Consumables, Instruments, and Software; By Technology, Fluorescence in situ hybridization (FISH), Genome Perturbation Tools, Microscopy-based Live DNA Imaging, Biochemical Techniques, Massively-Parallel Sequencing, and Other Technologies; By Application, Diagnostics and Disease Profiling, Drug Discovery, and Other Applications; By End-User, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, and Academic and Research Institutes; By Region and Companies), 2024-2033
Spatial Genomics Market growth is projected to reach USD 310.7 Million in 2023, at a 14.6% CAGR by driving industry size, share, segments research, top company analysis, trends and forecast report 2024 to 2033.